News

Muffin Recall Update as FDA Warns of Potential Metal Parts in Products
Products were distributed in New York, Pennsylvania, Massachusetts, New Jersey, Maryland, Virginia, Washington, D.C., North Carolina and Delaware.
The first drug to treat infants sick with malaria is approved by Swiss authority
Switzerland’s medical products authority has granted the first approval for a malaria medicine designed for small infants ...
The battle over buzz: Federal and state crackdowns on intoxicating hemp products escalate
Alexander Malyshev and Sarah Ganley of Carter Ledyard & Milburn LLP discuss a gray area when the 2018 Farm Bill legalized ...
National review identifies most effective skincare ingredients for common skin issues
From drugstore aisles to TikTok trends, consumers are bombarded with skincare products. But how do you know what really works ...
Stockhead on MSN12h
Health Check: POTUS puts drug tariffs back on agenda… another case of TACO?
Donald Trump again has threatened a tariff on imported drugs, but has given the drug makers a year or so "to get their act ...
Marijuana Moment21h
GOP Senator Who Helped Federally Legalize Hemp Is Seeking To Close ‘Loophole’ By Banning Products With Committee Vote This Week, Sources Say
The senator who championed the federal legalization of hemp is now seeking to reverse much of the reform by pushing ...
Aldi Food Recall Update: Customers in 37 States Told to 'Discard' Products
Recalled by RV Pharma on June 13 due to undeclared peanut allergen. Sold at Aldi locations in 37 states. Customers with ...
FOX 8 News on MSN5h
Urgent RITZ cracker sandwich recall; labeling error could cause life-threatening allergic reactions: FDA
The manufacturer of RITZ cracker sandwiches has announced an urgent recall due to a labeling error that the U.S. Food and ...
Emirates News Agency on MSN8h
Swiss authority approves first drug to treat infants sick with malaria
Switzerland’s medical products authority has granted the first approval for a malaria medicine designed for small infants, touted as an advance against a disease that takes hundreds of thousands of ...
DBV Technologies Begins Pivotal Peanut Allergy Study, Aims for 2026 FDA Submission.
DBV Technologies (NASDAQ: DBVT) is one of the best-performing NASDAQ stocks according to analysts. On June 25, DBV Technologies announced the screening of the first subject in its COMFORT Toddlers ...